Levels of some organochlorine residues in blood of patients with arteriosclerotic disease

A. Pines, S. Cucos, P. Ever-Hadani, Eldad Melamed, E. Pollak, R. Zevin-Pines

Research output: Contribution to journalArticlepeer-review

Abstract

This study aims to elucidate if any association exists between the development of arteriosclerotic disease and contamination of the internal human environment with certain organochlorine compounds (OCCs). For this purpose the levels of DDT isomers and their metabolites, and of lindane, dieldrin, heptachlor epoxide, and polychlorinated biphenyls (PCBs) were determined in blood serum of 11 patients suffering from slight to moderate (group A), and 24 patients with moderate to severe (group B), arteriosclerotic lesions. The control group consisted of 27 patients with no obvious manifestations of arteriosclerosis. The main findings of the study in comparison with the control group were: 1. (a) Mean OCC residue levels in blood were slightly higher in group A and markedly so in group B; 2. (b) The variability and the extent of departure from normality of distributions of organochlorine insecticides (OCIs) decreased, whereas those of PCBs increased, in arteriosclerotic patients (more markedly in group B); 3. (c) The degree of correlation between blood serum levels of various OCCs was elevated in group A and low in group B. It remains to be ascertained whether changes in the body burden of OCCs are primary, resulting from increased exposure to and absorption of these compounds which thus contribute to the development of arteriosclerosis, or are of secondary origin, due to inhibition of xenobiotic metabolism caused by interference of the arteriosclerotic process with the functions of drug metabolizing enzymes of liver microsomes.

Original languageEnglish
Pages (from-to)135-155
Number of pages21
JournalScience of the Total Environment
Volume54
Issue numberC
DOIs
StatePublished - Oct 1986
Externally publishedYes

Fingerprint

Dive into the research topics of 'Levels of some organochlorine residues in blood of patients with arteriosclerotic disease'. Together they form a unique fingerprint.

Cite this